Safety and Efficacy of Paxlovid in COVID-19 Treatment: A Rapid Review
Abstract Context: In the first stage of viral replication, COVID-19 may cause a remarkable inflammatory response in patients. Paxlovid is an oral antivirus medicine that functions through the inhibition of one of the essential enzymes to viral replication, called protease. The present study intends...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2022-10-01
|
| Series: | Health Technology Assessment in Action |
| Subjects: | |
| Online Access: | https://htainaction.tums.ac.ir/index.php/hta/article/view/130 |